We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

15 hedge funds and large institutions have $2.16M invested in Achieve Life Sciences in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.31% less ownership

Funds ownership: 1.1% → 0.78% (-0.31%)

6% less funds holding

Funds holding: 16 → 15 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

26% less capital invested

Capital invested by funds: $2.91M → $2.16M (-$751K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ARTA
A.R.T. Advisors
New York
+$36.7K
2
Morgan Stanley
Morgan Stanley
New York
+$33.3K
3
Wells Fargo
Wells Fargo
California
+$9.82K
4
UBS Group
UBS Group
Switzerland
+$6.41K
5
Victory Capital Management
Victory Capital Management
Texas
+$2.75K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$161K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$161K
3
WVP
Worth Venture Partners
New Jersey
-$113K
4
VF
Virtu Financial
New York
-$39.3K
5
Jane Street
Jane Street
New York
-$32K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sio Capital Management
New York
$892K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$407K -$161K -4,105 -26%
Vanguard Group
3
Vanguard Group
Pennsylvania
$328K -$161K -4,094 -30%
SC
4
Searle & Co
Connecticut
$225K – – –
VF
5
Virtu Financial
New York
$67K -$39.3K -1,001 -34%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$63K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$61K +$1.69K +43 +2%
ARTA
8
A.R.T. Advisors
New York
$32K +$36.7K +934 New
Morgan Stanley
9
Morgan Stanley
New York
$28K +$33.3K +848 +42,400%
WVP
10
Worth Venture Partners
New Jersey
$24K -$113K -2,871 -80%
BlackRock
11
BlackRock
New York
$14K – – –
Wells Fargo
12
Wells Fargo
California
$9K +$9.82K +250 New
UBS Group
13
UBS Group
Switzerland
$6K +$6.41K +163 New
Victory Capital Management
14
Victory Capital Management
Texas
$2K +$2.75K +70 New
Jane Street
15
Jane Street
New York
– -$32K -842 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$28K -718 Closed
Deutsche Bank
17
Deutsche Bank
Germany
– -$19K -512 Closed
JP Morgan Chase
18
JP Morgan Chase
New York
– -$2K -60 Closed
FDCDDQ
19
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$156 -4 Closed

ACHV Hedge Fund Activity: Q3 2019 in Review

15 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2019, worth a combined $2.16M — down 26% from $2.91M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ACHV and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.

The largest buyer was A.R.T. Advisors, opening a new position worth an estimated $36.7K. The largest seller was Renaissance Technologies, cutting an estimated $161K.

  • 15 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2019, down from 16 in Q2 2019.
  • Funds reported $2.16M of Achieve Life Sciences stock for Q3 2019, down 26% quarter-over-quarter.
  • 4 funds opened new Achieve Life Sciences positions in Q3 2019 and 5 closed out, a net change of -1 holder.
  • The largest Achieve Life Sciences buyer in Q3 2019 was A.R.T. Advisors, an estimated $36.7K added.
  • The largest Achieve Life Sciences seller in Q3 2019 was Renaissance Technologies, an estimated $161K sold.

Based on aggregated 13F filings for Q3 2019.